Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors.

Pasea, L; Chung, SC; Pujades-Rodriguez, M; Moayyeri, A; Denaxas, S; Fox, KA; Wallentin, L; Pocock, SJ; Timmis, A; Banerjee, A; +2 more... Patel, R; Hemingway, H; (2017) Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors. European heart journal. ISSN 0195-668X DOI: https://doi.org/10.1093/eurheartj/ehw683

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1093/eurheartj/ehw683

Abstract

Share

Download

Filename: Personalising the decision_GOLD VoR.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar